SRLS Insider Trading Activity and SEC Form 4 Filings
SRLS insider trading summary
No open-market insider purchases or sales of Seracare Life Sciences Inc (SRLS) have been reported on SEC Form 4 in the past 12 months.
Latest SRLS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 25, 2011 | Susan L N Vogt | President, CEO & Director | Buy | $42K (12,000 @ $3.51) |
| Aug 17, 2010 | Susan L N Vogt | President, CEO & Director | Buy | $30K (8,303 @ $3.57) |
| Aug 16, 2010 | Susan L N Vogt | President, CEO & Director | Buy | $22K (6,697 @ $3.31) |
| Feb 18, 2010 | David Olsen | V.P., Corporate Quality | Sell | $16K (4,478 @ $3.55) |
| Feb 17, 2010 | David Olsen | V.P., Corporate Quality | Sell | $14K (4,000 @ $3.46) |
| Feb 24, 2009 | Hmc - New York, Inc. | 10% Owner | Sell | $917K (3,398,083 @ $0.27) |
| Feb 24, 2009 | Philip Falcone | 10% Owner | Sell | $917K (3,398,083 @ $0.27) |
| Feb 24, 2009 | Harbinger Capital Partners Offshore Manager, L.L.C. | 10% Owner | Sell | $44K (164,486 @ $0.27) |
| Feb 24, 2009 | Hmc Investors, L.L.C. | 10% Owner | Sell | $917K (3,398,083 @ $0.27) |
| Feb 24, 2009 | Harbinger Capital Partners Special Situations Fund, L.P. | 10% Owner | Sell | $917K (3,398,083 @ $0.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.